Related Experiment Video
Updated: May 15, 2026

Exploring Protein-Glycan Interactions: Advances in Nuclear Magnetic Resonance
Published on: August 26, 2025
Native MS and ligand observed NMR uncovers subtle SLiM binding variations that mediate HSP90-Hop PPI modulation
Tara K Davids1, Daniel A Kusza1, Shannon K Misplon1
1Department of Chemistry, University of Cape Town, Rondebosch Cape Town 7701 South Africa Marwaan.rylands@uct.ac.za Clinton.veale@uct.ac.za.
Abstract:
We have previously demonstrated that a non-natural tetrazole containing peptide (2), which mimics the MEEVD Short Linear Motif (SLiM) found at the Heat Shock Protein 90 (HSP90) C-terminus, disrupts the transient protein-protein interaction (PPI) formed between HSP90 and the HSP70-HSP90 organizing protein (Hop) co-chaperone. However, the native MEEVD SLiM (1) showed negligible inhibitory activity despite similar binding affinity to the interacting HopTPR2A domain. To investigate the origin of this discrepancy, we combined native mass spectrometry (nMS) coupled to ion mobility (IM) with saturation transfer difference (STD) and water ligand observed via gradient spectroscopy (WLOGSY) NMR to interrogate the interaction of peptides 1 and 2 alongside a series of peptide derivatives with HopTPR2A. Collectively, these data revealed that the variation in sequence between peptides 1 and 2 imparts subtle variations in conformational stability and magnetization transfer, indicating that differences in PPI modulation arise from altered binding mode rather than binding affinity. These results not only provide a structural framework for developing peptidomimetic HSP90-Hop PPI inhibitors, but a generalized strategy for exploiting transient PPIs for drug discovery.
Insights
A novel tetrazole-containing peptide disrupts Heat Shock Protein 90 (HSP90) interactions by altering its binding mode, not affinity. This discovery offers a new strategy for developing protein-protein interaction (PPI) inhibitors for drug discovery.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- Heat Shock Protein 90 (HSP90) is crucial for cellular proteostasis.
- HSP90 interacts with co-chaperones like Hop via its C-terminal MEEVD motif.
- Targeting HSP90-co-chaperone interactions is a promising therapeutic strategy.
Purpose of the Study:
- Investigate why a non-natural tetrazole peptide (2) inhibits HSP90-Hop interaction more effectively than the native MEEVD motif (1).
- Determine the structural basis for differential inhibition of protein-protein interactions (PPIs).
Main Methods:
- Native mass spectrometry (nMS) with ion mobility (IM).
- Saturation transfer difference (STD) NMR.
- Water ligand observed via gradient spectroscopy (WLOGSY) NMR.
- Analysis of peptide derivatives binding to the HopTPR2A domain.
Main Results:
- Peptide 2, mimicking the MEEVD motif, disrupts HSP90-Hop PPIs.
- Native MEEVD peptide (1) showed weak inhibition despite similar binding affinity.
- Differences in PPI modulation stem from altered binding modes, not affinity, due to sequence variations.
- Conformational stability and magnetization transfer varied subtly between peptides.
Conclusions:
- The study provides a structural basis for designing peptidomimetic inhibitors of HSP90-Hop PPIs.
- Altered binding modes, rather than affinity, are key to modulating transient PPIs.
- A generalized strategy for targeting transient PPIs in drug discovery is presented.
Related Concept Videos
Ligand Binding and Linkage
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Cooperative Allosteric Transitions

